Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Hygea Medical Raises $77 Million for Minimally Invasive Surgery Devices

publication date: May 12, 2021

Beijing Hygea Medical Technology completed a $77 million Series C financing to support its medical devices, including a low temperature minimally invasive ablation device for cancer and atrial fibrillation. Hygea said it would use the proceeds to accelerate its marketing and build a sales channel for its core product, the Kangbo Knife. The company has started an AI program to develop new minimally invasive surgery products. It is also applying its ablation technology to treat atrial fibrillation. The financing was led by China Growth Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021